Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.

Solidifying Boyd's Position as a Leading Player in the North American Collision Industry WINNIPEG, MB, Jan. 9, 2026 /PRNewswire/ - Boyd Group Services Inc. (TSX: BYD) (NYSE: BGSI) ("BGSI", "the Boyd Group", "Boyd" or "the Company") today announced the closing of the acquisition of Joe Hudson's Collision Center ("Joe Hudson's"), the definitive agreement to acquire Joe Hudson's having been previously announced on October 29, 2025. The acquisition adds 258 locations across the US Southeast region, increasing Boyd's North American location footprint by 25% to 1,301.

BRISBANE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on January 5, 2026, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 228,750 shares of Class A common stock and restricted stock units (RSUs) underlying 116,000 shares of Class A common stock to eighteen (18) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan).

Does Pioneer Power Solutions, Inc. (PPSI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does Aptiv PLC (APTV) have what it takes to be a top stock pick for momentum investors? Let's find out.

Regeneron (REGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Does Banco Santander (SAN) have what it takes to be a top stock pick for momentum investors? Let's find out.

AN2 Therapeutics (ANTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Black Diamond (BDTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Revolve Group (RVLV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Apple shares extended a rare period of weakness this week, slipping 0.5% to $259.04 on Thursday and marking the stock's seventh consecutive session of declines dating back to Dec. 30. While the pullback has been relatively modest — Apple shares are down about 5.

Carvana (CVNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Corteva, Inc. (CTVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Rimini Street (RMNI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Ares Commercial Real Estate (ACRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Nuclear power and private jets take @Stockstotrade's Tim Bohen's attention on today's Big 3. Tim points to Oklo Inc.'s (OKLO) cooldown as a new base for shares, Cameco's (CCJ) "safer" exposure to the nuclear sector, and Flyexecutive's (FLYX) SpaceX tie as reasons to watch his stock picks.

Meritage Homes faces near-term headwinds from high mortgage rates and incentives but trades at a significant discount to tangible book value. MTH is expanding its community count, positioning for strong growth as rates fall and affordability improves. Management is leveraging faster build times, realtor incentives, and rebidding land development to mitigate margin pressures and prepare for a housing recovery.

SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is notifying investors in StubHub Holdings, Inc. (NYSE: STUB) of the upcoming January 23, 2026, lead plaintiff deadline in a pending securities class action. The firm is investigating whether StubHub's September 2025 Initial Public Offering (IPO) documents failed to disclose critical known trends that resulted in a 143% collapse in free cash flow, as alleged in the pending suit.

SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation (NYSE: PRMB) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026. The firm urges investors who suffered substantial losses to contact our firm now.

LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today congratulates Aktis Oncology (Nasdaq: AKTS), a clinical-stage biotechnology company advancing a pipeline of alpha-emitting radiopharmaceuticals for the treatment of solid tumors. Aktis raised $318 million in its initial public offering, reflecting strong investor interest, its recently announced anchor investment by Eli Lilly and Company (NYSE: LLY), and pipeline momentum as the co.